I am pleased to report that
the Company has once again achieved
record orders, revenues, net income and
operating cash flow., and a central European sales and
distribution
operation in the Netherlands, has one of the most extensive
offerings of dry-break couplers in the
industry. The implementation of this accounting standard is expected to
reduce net income by $1
.1 million (53%) to $369.0 million (74%). This increase was primarily due to acquisitions and
increased
volume of compressor and blower shipments in the U. Selling and administrative
expenses increased
$84.
Other income-net increased $4.1 million in 2004.5 % on June 30, 2005, pro forma for the
acquisition of
Thomas Industries, which was completed July 1.6% 16.0) -4%
(2.0 86% 4.8% 16.3 75% 3.4 52% 21.9) -5% 3.6% 37.
PHARMtechexpo
2005 Exhibitor Profiles
Magnus Welander
Phone: +49 (69) 69 76 79 23
E-mail: joerg. The
facility
near Heidelberg, Germany, fully meets the quality standards
of the pharmaceutical industry and is
EN ISO 9001-2000 certified. Formulation
development of poorly soluble substances, the development
of
analytical methods, registration support and full-scale manufacturing
services are representative
examples. Tuthill Corporation is a privately owned company
manufacturing a broad range of industrial
products in 35 locations
worldwide.robuschi vacuum
Our strategic acquisitions, internal revenue growth and
cost
reduction initiatives continue to result in increased earnings and cash
flow for our shareholders
.25 to
$3.5% of revenues in the three months ended December 31, 2005, an increase
from 7.0% in
the prior year period.
Net income for the three months ended December 31, 2005 increased $11
.0 billion in 2005. and China,
partially offset by foreign currency exchange rate fluctuations.3%
in 2004, due to the
leverage of incremental revenue volume and the completion of various
integration
activities and cost reductions. As a general matter, forward-looking statements are
those focused
upon anticipated events or trends, expectations, and beliefs
relating to matters that are not historical
in nature. These uncertainties and
factors could cause actual results to differ materially from
those matters
expressed in or implied by such forward-looking statements.96 $0.92 43
Basic weighted average
number of shares
outstanding 25,976 19,880
23,914 18,955
Diluted weighted average
number of shares
outstanding
26,523 20,389 24,455 19,377
Shares outstanding
as of 12/31
25,999 19,948
CONDENSED BALANCE SHEET ITEMS
(in thousands, except percentages)
(Unaudited)
%
12/31/05 9
/30/05 Change 12/31/04
Cash and equivalents $110,906 $114,556 (3)
$$64,601
Receivables, net 229,467 228,578 --- 163,927
Inventories
, net 207,326 214,033 (3) 138,386
Current assets 586,267
594,849 (1) 385,522
Total assets 1,718,068 1,733,755
(1) 1,028,609
Short-term debt and
cur.1 64%
Effect of currency
exchange rates (7.6 213%
Backlog as of 12/31/05
161.1 32.8 2.0%
Total Segment Operating Earnings
2004 22.9%
Net Income
2004 13.
The
NOWPak (R) product line offers critical liquids packaging and
dispensing systems.SUMIT JAIN
Phone:
91-22-26780652/2653/2656
E-mail: SKJ@FDCEXPORT.ECONOZOLE NITRATE
6.com
Web:
www.P. We
are certified and practising ISO 9001:2000 and GMP standard. Your future oriented partner
for innovative primary packaging!
Company: Solupharm GmbH
Media/Investor Relations Contact:
Mr.wintek recirculating
Gardner Denver Inc. Reports Record Level Revenues Net Income and Operating Cash Flow In 2005:
Fourth Quarter Revenues Increase 53% and Net Income Increases
3 million, a 53% increase compared to
the fourth quarter of
the previous year, primarily as a result of acquisitions completed in 2005
and
strong organic growth. Diluted earnings per share for the three months of
2005 was $0.5 million
in 2005.96, 43%
higher than the previous year.69 42 $2. maturities 542,641 596
,581 (9) 280,256
Total liabilities 1,059,779 1,095,792 (3) 623
,133
Total stockholders'
equity 658,289 637,963 3
405,476
GARDNER DENVER, INC.8 6%
2005 Revenues
306.3 34% 65.9 210%
GARDNER
DENVER, INC.7 40%
2005 45.9 65% 20. For in-depth information
about the
event visit http://www.
Company: MRC Systems Ltd
Booth/Stand: B 06
Media/Investor
Relations Contact: Dr Amer Mutter
Phone: + 44 1252 704500
E-mail: office@mrc-systems. Due to geographical
position
of LUKAPS HARD GELATINE CAPSULES PLANT, door-to-door delivery of
Lukaps capsules is the
most commonly used way of transportation. Our unique integrated offering of
validated capital equipment
, cleaning chemistries, and services allows
STERIS to support the pharmaceutical process from research
and
discovery to manufacturing. FlowPro internal Gear and Rotary Piston
Pumps in 316 stainless
steel and ductile iron for flow rates up to
148m(3)/hr at temperatures from -40 degrees C to 316
degrees C and
pressures up to 27 bar. Tuthill Pump Group has manufacturing plants in the USA and
UK.Industrial, scientific, laboratory, and medical vacuum pumps.
pvr nsb
Net income for the three months
ended December 31,
2005 was $25. This increase is attributable to margin
improvements realized
at Nash Elmo since its acquisition, cost reductions
initiated at Thomas Industries' operations and
year-end adjustments to selling
and administrative expenses, partially offset by increased material
,
compensation and fringe benefit expenses.S. These positive factors were
partially offset by higher
material costs and some supply chain inefficiencies
that affected material availability.
As
a percentage of revenues, selling and administrative expenses decreased
to 20.4 million in 2005,
compared to
$157. Days
sales outstanding decreased for the fifth consecutive quarter to 57 days
,
compared to 63 days at the end of 2004. Gardner Denver's news releases are available
by visiting
the Investor Relations page on the Company's website
(http://www.2
Effect of currency
exchange rates (1.3 66% 33.5 21.9 109% 12. Headquarters, R+D, manufacturing
,
and testing facilities are located in Lagga Marma - just 20 minutes
from the Stockholm-Arlanda
airport. Please visit www. FDC Ltd has
USFDA approved API manufacturing facilities.
Company
description: Pharmadule is the world-leading supplier of
modular facilities to the Pharma and Biotech
industries. The company
is located in Sweden and has an office also in New Jersey, USA, and
Geneva
, Switzerland.com/pharmaceutical_packaging
Product description:
- Prefillable syringes
made of glass
and COC polymer
- Vials made of glass and COC polymer
- Cartridges for different drug delivery systems
- Ampoules made of glass
- Special
articles
Company description: SCHOTT forma vitrum is one of the leading
suppliers of parenteral
packaging for the pharmaceutical industry. Friedemann Seitz
Phone: 00495661730510
E-mail: friedemann
.neuberger wob
Finally, we used
cash generated from operations and cash repatriated from our international
subsidiaries
to significantly reduce our debt in the fourth quarter," stated
Ross Centanni, Chairman, President
and CEO.1
million of cash. Manufacturing capacity
utilization in the U.75.6 million to $4.
The
weighted average interest rate for the three-month period of 2005 was
6.7 million shares in May 2005
and a
higher effective tax rate in 2005 (30%), compared to the previous year.
Full Year
Results
Revenues increased $475.5 million in incremental revenues. Acquisitions
(net of cost
reductions realized) also positively impacted gross margin
percentage, as their gross margin percentage
for the year was higher than the
Company's previously existing businesses. The Fluid
Transfer
Products segment generated operating margin of 15.4 million in 2005,
compared to 2004, due to higher
average borrowings to fund acquisitions and
higher average rates during the year.com) or
through
Thomson StreetEvents at http://www.earnings.
SELECTED FINANCIAL DATA SCHEDULE
(in millions, except percentages)
(Unaudited
)
Three Months Ended Twelve Months Ended
December 31, December 31,
% %
Change
Change
Compressor and Vacuum Products
2004 Revenues $193.6
70%
2004 Orders 195.5 44%
2005 Revenues
63.4 54% 20.3 54%
2005 25.pharmtechexpo.tradeshownews.g.
The
Newmix(TM) product line supplies sterile single-use non-invasive
mixing and storing systems.
Company: Envirotainer
Booth/Stand: E12
Media Contact: Mr.MICONAZOLE BASE
12. Innovative gamma-irradiated, triple
bagged products with long shelf life and room temperature
storage have
been established. Pharmadule has delivered close to 50 facilities
worldwide to companies
such as Eli Lilly, Merck + Co, Aventis Pasteur,
Baxter and AstraZeneca.g.com
Web: www.
Company
description: Tuthill Pump Group is a Division of the
Tuthill Corporation.priming desuperheaters
"
"Our efforts to
integrate acquired businesses remain on plan.5 million.3 million, compared to $13.gardnerdenver.5
64%
Effect of currency
exchange rates (7.3
Incremental effect
of
acquisitions 105.9
Incremental effect of
acquisitions
90.9 63% 151.5 51%
Effect of currency
exchange rates (8.1) -3% (2.0 13% 102.5%
We secure
the critical link between DCS systems + automated
sanitary and non-sanitary process devices applied
in the entire
Bio/Pharma manufacturing process. LTD
Booth/Stand: B 11 in Hall B
Investor Relations
Contact: Anthony Aguiar
Phone: + 91 22 24938565
E-mail: anthony@metroexporters.HU
Web:WWW. In
order to meet specified and expected demands we
have created and apply MSZ EN ISO 9002 quality management
system and
we have AD 2000 Merkblatt HP0 and DIN EN 729-2 certificate.solupharm.vane desuperheaters
0 million, respectively;
the
Company's highest levels since becoming an independent entity in 1994. Cash generated by
operations
increased 55% to $119 million in 2005, compared to $77 million in
the previous year. The integration
of Thomas Industries, while
in the early stages, has already yielded annualized administrative synergies
in excess of $4. Acquisitions
accounted for approximately two-thirds of this increase, with organic
growth
generating the remainder.7
million (86%) to $25.
The Company invested approximately
$35.8 45% 34.1 55% 35.5 58% 34.6 5.16.59
E-mail: info@atmipackaging
.
Company: DIAMOND SCIENTIFIC LTD
Booth/Stand: B04
Media/Investor Relations Contact: GUY
PIERCE
Phone: (44) 1325 481048
E-mail: (44) 1325 484656
Web: www. "Metro" has been a supplier
to the pharmaceutical industry
since the 1980's .PATENT. This
medium-sized family company, which
guarantees each of its customers
individual and personal attention, it goes without saying that your
desires and expectations are fulfilled in accordance to GMP. They are suitable for dosing and
injection
and are pulse free.schoolroom vane
We strengthened our
manufacturing processes through the use of lean practices
, and used these
tools to help some of our suppliers reduce their lead-times. Many of the world's
largest
oil, chemical and gas companies rely on TODO-MATIC(R) self-sealing couplings
to safely
and efficiently transfer their products. Year-end adjustments reduced selling and
administrative
expenses approximately $2. The improvement in net income and DEPS was
primarily attributable to
the incremental benefit of acquisitions, cost
reductions and synergy savings, and higher revenue
volume and the related
leverage of fixed and semi-fixed expenses. These results include
approximately
$2.
Interest expense increased $20.67 43 $2.6) -4% (2.6
10% 44.7
Effect of currency
exchange rates (1.4%
Incremental
effect of
acquisitions 12.com
Web: www. The company is a leading worldwide
provider
of calibration solutions that meet even the most demanding
requirements.hall@casburt.
Company
description: Casburt Ltd has over 50 years experience and a
proven reputation in the supply of tablet
compression machines and
drying ovens to the pharmaceutical and associated industries.relation@DSM
.OXYBUTYNIN HYDROCHLORIDE
14. KG
Booth/Stand: D004
Media/Investor Relations
Contact: Peter Jaschke
Phone: +49 711 347 1856
E-mail: pja@festo. KG is a global solution
provider
for automated handling systems and for plant process control
systems.
Booth/Stand: HALL B / F05
Media Contact: GABRIELLA KOCSIS
Phone: +36 53 505 570
E-mail: PATENT@PATENT. We manufacture
and supply
complete ranges of vacuum pumps, vacuum boosters and systems.
priming schoolroom
K. Centanni stated
, "In 2006, I anticipate further cost
reductions and acquisition integration savings. exceeded the
key threshold level of 80% for two
consecutive months in the fourth quarter of 2005."
"Demand
for our drilling and well stimulation pumps is extremely strong
and we expect this to continue throughout
2006 and into 2007.45, with first quarter DEPS approximating $0. The after-tax effect of these expenses
is estimated to be in a range of $3.
Operating earnings for the Compressor and Vacuum Products
segment were
10.4% in the same period of 2004.6% for the three months ended December 31,
2005
, compared to 16. Fluid
Transfer Products segment revenues increased 43% to $214.9 million (80%)
to $67.6) --
Other changes 29.
SELECTED FINANCIAL
DATA SCHEDULE
(in millions, except percentages)
(Unaudited)
Three Months Ended Twelve Months Ended
December 31, December 31,
% % of % % of
Change
Revenues Change Revenues
Revenues
2004 Revenues $241.1% 61.2
55% 11.7% 9.
Company: FDC LIMITED
Booth/Stand: C09
Media/Investor Relations
Contact: MR. FDC invites companies interested in contract manufacturing of
API'S and finished dosage
forms at their facilities.com
Web: www.com
Web: www. R.com
Product description: Technaflo
magnet-drive gear pumps in stainless
steel, PPS, hastelloy 'C' and titanium.priming javac
For the twelve-month
period of 2005, orders for drilling pumps and well
servicing pumps increased more than 300% and 100
%, respectively, compared to
the previous year. Previous capital investments to improve production
efficiencies enabled us to realize much of this order growth in revenues. I believe broader
implementation
of our lean manufacturing techniques will contribute to
inventory reductions and production efficiency
improvements. Fluid Transfer
Products segment revenues increased 32% for the three months ended
December
31, 2005, compared to the same period of 2004, due to strong organic growth in
drilling
and well servicing pump shipments and price increases (See Selected
Financial Data Schedule). This
improvement was
attributable to the benefit of cost leverage over a higher revenue base,
favorable
mix, price increases and operational improvements.
Incremental borrowings necessary to complete
acquisitions in 2005 and
higher effective interest rates resulted in increased interest expense for
the
three months ended December 31, 2005, compared to the same period of 2004.6 million in same period
of
2004. This improvement reflects the increased leverage of the
revenue growth, with a continued
focus on working capital management.
CONSOLIDATED STATEMENT OF OPERATIONS
(in thousands, except per share amounts and percentages)
(Unaudited)
Three Months Ended Twelve Months Ended
December 31, December 31,
% %
2005 2004 Change 2005
2004 Change
Revenues $369,287 $ 241,198 53 $1,214,552 $739,539 64
Costs and Expenses:
Cost of sales 243,778 161,978 51 813,227 498
,435 63
Depreciation and
amortization 12,506 5,827 115 38,322 21
,901 75
Selling and
administrative 67,123 51,422 31 242,368 157,453
54
Interest expense 10,791 4,153 160 30,433 10,102 201
Other (income
)
expense, net (1,104) 1,118 NM (5,442) (638) NM
Total costs and
expenses 333,094 224,498 48 1,118,908 687,253 63
Income before
income taxes 36,193 16,700 117 95,644 52,286 83
Provision for
income taxes 10,858 3,064 254 28,693 15,163 89
Net income
$25,335 $13,636 86 $66,951 $37,123 80
Basic earnings
per share
$0.4 28%
Backlog as of 12/31/05 298.9) -1%
Other changes 33.0%
Incremental effect of
acquisitions 2
.6%
Other changes 8.
Company description: Envirotainer is represented at several
locations in 13 countries worldwide.BROMHEXINE HYDROCHLORIDE
3.MICONAZOLE
NITRATE
13.PHENYLEPHRIN HCL
Company description: FDC Limited offers
wide range of API's and
finished dosage form from its WHO-GMP approved and internationally
accredited
six manufacturing facilities across India.com
Product description: The product range includes
a full line of
culture media for hygiene monitoring in cleanrooms and isolators as
well as sterility
testing media.metroexporters.HU
Company description: PATENT LTD.
Areas of Expertise: Biopharmaceuticals
, Chemical API, Fill +
Finish with Aseptic Processing and Oral Solid Dosage.schott.steris.schoolroom ejectors
4% in 2004
. We realized significant
order growth for compressor and pump products serving the energy market
and
blowers used for mobile applications in North America, and improved demand for
compressors
used in industrial applications.
"Demand for our drilling and well stimulation pumps has been
exceptional.8 million pretax gain and generating $2.2 billion in 2005, compared
to $739.
The
Compressor and Vacuum Products segment generated operating margin of
8.8 million in 2005 to $5.
Diluted earnings per share for the twelve
months of 2005 was $2.74, 43% higher than the previous
year.0 million) and the Thomas Industries acquisition for 6 months ($2. The
increase in DEPS was
partially offset by higher average shares outstanding for
the twelve-month period of 2005, as compared
to 2004.
Cash provided by operating activities increased 55% to approximately $119
million
in 2005. At year-end, debt to total capital was
46. The Company does not undertake, and
hereby
disclaims, any duty to update these forward-looking statements,
although its situation and circumstances
may change in the future.
Gardner Denver will broadcast a conference call to discuss fourth quarter
earnings on Tuesday, February 7, 2006 at 9:30 a.4
Incremental effect of
acquisitions
103.3 61% 326.2 $739.7% 132.com
Product
description: The Newform(TM) product line supplies high
performance packaging solutions for advanced
purity components and
active ingredients.beamex.
Company description: Beamex is a technology
and service company
that develops, manufactures and markets high-quality calibration
equipment
, software, systems and services for the calibration and
maintenance of process instruments.
The
company creates innovative products and services that help improve
the quality of life.envirotainer
.FDCINDIA.COM
Product description: LIST OF API PRODUCT LIST
1.com
Web:
www.mrc-systems.rpscherer.seitz@solupharm.com
Product description: Contract manufacturing of
sterile solutions
in glass ampoules or glass vials (e. The pumps have displacements
from 0.
Company description: Tuthill Vacuum + Blower Systems is a Division
of the Tuthill Corporation
. Tuthill Corporation is a privately owned
company manufacturing a broad range of industrial products
in 35
locations worldwide.rietschle leybold
Diluted earnings per share (DEPS) for the twelve months of 2005 was
$2. Further synergistic benefits through facility and
product rationalization, sales channel leverage
and material cost reductions
are planned in 2006 for realization in early 2007.5 million
(approximately
$15 million), net of debt and cash acquired. Our
manufacturing presence in Asia will enable our
participation in the continued
dynamic growth for industrial products in this region. A
disproportionate
amount of this expense will be recognized in the first
quarter of 2006, due to the number of options
held by employees eligible for
retirement. Orders for the three-month period of
2005 were $146
.5 million (60%) higher than the same period of the previous
year, due to acquisitions (43%) and organic
growth (17%). This
improvement was attributable to the benefit of leveraging costs over
additional
production volume, acquisitions and price increases. Favorable
sales mix also contributed to increased
gross margin as the fourth quarter of
2005 included a higher percentage of drilling pump sales than
the previous
year.4 million in the fourth quarter of
2005.9%, compared to 5.5 million in 2004
.9 million (54%) to $242.3 million to $30.4%, compared to 51.com).
GARDNER DENVER, INC.4% 8.7 9% 36.6 86%
Backlog
as of 12/31/04 52.3% 157.
Company: Casburt Ltd
Booth/Stand:
D15
Media Contact: John Hall
Phone: +44 7967 381931
E-mail: john.com
Product description:
Under the banner of "UNCOMPLICATED
TABLETING", the company manufactures its own range of TECHNIPRESS
Tablet Presses - reliable, medium output production machines which are
very simple to clean and
maintain The Technipress is supported by a
full range of ancillary equipment and a comprehensive
spare parts and
tooling service. The machine has proven popular with pharmaceutical
and contract
manufacturers and R+D facilities.
- Validation of safety cabinets, laminar flow cabinets, fume
cupboards and isolators.com
Phone: +31 46 47 73827
E-mail: Herman-J.COM
Web: WWW
.BISACODYL
2.CINNARIZINE
4.TIMOLOL MALEATE
17. The products are offered
with DMF and the DMF's are registered with USFDA as
well as COS
granted.
Company: heipha Dr.
Company: PATENT METAL FABRICATING LTD.de
Product description:
- Soft Capsules (Pharmaceuticals and Food Supplements)
- Formulation Development
- Production
- Packaging
Company
description: R. PC LUKAPS
Booth/Stand: GO2
Phone: 00385 42 810 679
E-mail: lukaps@razvitak
.
Company: SCHOTT forma vitrum
Booth/Stand: B01
Media Contact: Philipp Tappert
Phone:
+ 36 (0) 94 - 568 - 424
E-mail: philipp.com
Product description: STERIS's family of products
include such
famous name brands as: Finn-Aqua: GMP sterilizers, water stills and
pure steam generators
Lyovac: Freeze drying systems Reliance and HAMO:
GMP and laboratory washing systems STERIS Corporation:
Low temperature
VHP biodecontamination systems, cleanroom chemistries and process
research cleaners
Company description: STERIS's Life Sciences Group is the recognized
expert in preventing contamination
by providing superior products and
services throughout the world. Does not include household vacuum
cleaners.
wintek vooner
(NYSE: GDI) announced that revenues and net income for the twelve months ended
December
31, 2005 were $1.65 to $0. In
2004, the effective annual tax rate was reduced to 29% through a decrease
in
the fourth quarter effective tax rate to 18%, arising from a one-time
favorable tax audit settlement
.9 million in 2005,
driven by increased shipments in all product lines, but in particular drilling
and well stimulation pumps, and price increases. This improvement was primarily attributable to
the
positive effect of increased cost leverage over a higher revenue base,
favorable mix, operational
improvements and price increases. Income taxes increased in 2005,
compared to the previous year
, due to higher pretax income and a slightly
higher rate in 2005 (30%) than in 2004 (29%).gardnerdenver
.80 $1.9% 10.2 $589.7) --
Other changes 19.1
) -2% (0.1 11%
2005 125.9 3.0%
Incremental
effect of
acquisitions 5.6 76% 4.7 29% (0.5 2%
2005 67.
Company description: ATMI Packaging NV is a global manufacturer
of
a wide variety of ultra-clean flexible packaging solutions and
single-use mixing and storing
systems for the BioPharmaceutical
industry.com
Web: www.dsmpharmachemicals.com
for more information
.reidelshoefer@cardinal.P.hr
Web: www. local anaesthetika, heparine
solutions, standard electrolyts
, homoepathic solutions, vitamines).002 to 12 ml/rev at pressures up to 17 bar and temperatures
from
-46 degrees C to 176 degrees C.tuthillvacuum.vooner kerrick
To reduce
potential manufacturing bottlenecks, we
will continue to outsource machining
operations to smooth our production processes and we expect
to continue to
ship product at rates that satisfy our customers' requirements," noted Mr.35) represents
a 22% increase over the 2005 results.8% in the same period of 2004.7 million of net income from Thomas
Industries' operations
for the three months ended December 31, 2005. Higher compensation
and
fringe benefit costs also contributed to this increase. During the fourth quarter of 2005, the Company
repatriated
approximately $44 million of excess cash from its foreign subsidiaries and
used the
proceeds to repay debt.
Cautionary Statement Regarding Forward-Looking Statements
All of the statements in this release, other than historical facts, are
forward-looking statements
made in reliance upon the safe harbor of the
Private Securities Litigation Reform Act of 1995, including
, without
limitation, the statements made under the "CEO's Comments Regarding Results"
and "Outlook
" sections. Eastern time, through a
live webcast.5
Incremental effect of
acquisitions
103.2%
Selling + Administrative
2004 51.7%
Other changes (2.1 55% 9.61.diamondscientific.uk
Product description:
- Cleanroom validation, balancing and certification.krings@envirotainer.METAXALONE
11.600 people in 52 own national companies in 250
global subsidiaries.
Company:
Haupt Pharma AG
Booth/Stand: E18
Media Contact: Hans-Wolfram Hardtke
Phone: +49-172-3002139
E-mail: hans-wolfram. Ulrich Eikmanns
Investor Relations Contact: Dr. Additionally heipha offers
a wide range of special
media in petri-dishes, contact plates, bottles and tubes.KG
Booth/Stand:
D - 16
Phone: +49 6271 945 3060
E-mail: alfred.Scherer is a fully integrated service
provider
for the health care industry offering a broad range of
encapsulation products and services from one
location. LUKAPS HARD GELATINE CAPSULES PLANT was established 23 years
ago under Razvitak joint-stock
company located in Ludbreg (80 km far
from Zagreb) and today is a leader in hard gelatine capsules
business
in the middle of Europe. The
Kinney traditional liquid ring vacuum pumps and the Atlantic
Fluidics
range of single and multi-stage pumps featuring Fluid-Vac axial flow
technology for efficient
, vibration-free operation.recirculating robuschi
2 million for the year. The improvement in DEPS is net
of the dilutive
effect of the issuance of 5.9% in 2004. Net income for
2005 includes the incremental effect of the
Nash Elmo acquisition for 8 months
($7.96 43
Diluted earnings
per share
$0.0%
Orders 76,309 47,503 61 326,615 175,728 86
Backlog
161,889 52,271 210 161,889 52,271 210
Reconciliation of
Segment Results
to Consolidated Results
Compressor and
Vacuum Products
operating
earnings $32,252 $14,259 $86,402 $46,681
Fluid
Transfer
Products
operating
earnings 13,628 7,712
34,233 15,069
Total segment
operating
earnings 45,880 21,971
120,635 61,750
Interest expense 10,791 4,153 30,433 10,102
Other (income)
expense, net (1,104) 1,118 (5,442) (638)
Income before
income taxes $36,193 $16,700 $95,644 $52,286
GARDNER DENVER, INC.5 13% 28.1%
Other changes
11. Martin Peter
Investor Relations Contact: Mr.envirotainer.FLUNARIZINE DIHYDROCHLORIDE
8. Over 50 years of experience in
providing handling solutions, pneumatic
controls, serial
communications and bus systems, provides us the engineering and
application expertise
.
Company description: Festo is an independent, family owned
solutions provider for industrial
and process automation.
heipha operates in accordance with GMP-guidelines supported by a
comprehensive
quality management system.
Company: R.com
Web: www.
Company: Tuthill Vacuum + Blower
Systems
Booth/Stand: G01
Media Contact: John Westwood
Phone: +44 1323 749021
E-mail: jwestwood@tuthill
.com
Web: www.pvr moorfield
, Gardner Denver, Inc.74, 43%
higher than the previous year. We will continue to
seek opportunities to reduce costs and
sell excess assets in 2006, as we further streamline our operations
. The midpoint of
this range ($3. This
improvement is expected despite the reduction in DEPS
associated with
expensing stock options for the first time in 2006 and a greater number of
average
shares outstanding for the twelve-month period of 2006, as compared to
2005.0 million in the first
quarter of
2006.
Gross margin (defined as revenues less cost of sales) as a percentage of
sales (gross margin percentage) increased to 34. The Fluid Transfer Products segment
operating
margin increased to 21. Diluted earnings per share for the three months of 2005 was $0. For the twelve
-month period of 2005, Nash Elmo net income was $11. dollar, the Euro, the British pound and the
Chinese
yuan); (9) the risks associated with pending asbestos and silicosis
personal injury lawsuits, as
well as other potential product liability and
warranty claims due to the nature of the Company's
products; (10) the risks
associated with environmental compliance costs and liabilities; (11) the
ability to attract and retain quality management personnel; (12) the ability
to avoid employee
work stoppages and other labor difficulties; (13) the risks
associated with defending against potential
intellectual property claims and
enforcing intellectual property rights; (14) market performance
of pension
plan assets and changes in discount rates used for actuarial assumptions in
pension
and other postretirement obligation and expense calculations; (15) the
risk of possible future charges
if the Company determines that the value of
goodwill or other intangible assets has been impaired;
and (16) changes in
laws and regulations, including accounting standards, tax requirements and
related
interpretations or guidance.2 billion ($1. maturities 26,081 31,332 (17)
32,949
Accounts payable and
accrued liabilities 306,160 285,141 7
206,069
Current liabilities 332,241 316,473 5 239,018
Long
-term debt, ex.
cur.1% 15.2 53% 375.1) -2%
(0.5 175.3
Effect of currency
exchange rates
(2.0) -3%
Other changes 111
.6%
Incremental effect of
acquisitions 35.2%
Other changes
10.0% 401.
Business Editors/High-Tech Writers
PHARMtechexpo 2005
PRAGUE, Czech
Republic----PHARMtechexpo 2005 takes place February 9-10 at the Veletrzni
Palac in Prague, Czech
Republic. e.
Company: Beamex Oy Ab
Booth/Stand: B05
Media Contact: Mr. Villy Lindfelt
Investor
Relations Contact: Mr. Combining advanced container technology with a network of
airlines, forwarders
, and other logistics providers, Envirotainer
offers solutions worldwide that preserve the freshness
, functionality,
integrity and safety of products shipped by air.hardtke@haupt-pharma. Separate production
sites for
oral hormone products and cytostatic agents.net
Web: www.
Company description:
LUKAPS - a well known manufacturer from
Croatia of hard gelatine capsules made from pharmaceutical
grade
gelatine.priming blowers
For the twelve-month period, total segment
operating earnings (defined as revenues
less cost of sales, depreciation and
amortization, and selling and administrative expenses) as a
percentage of
revenues (operating margin) for the Company increased to 9. We completed the
previously
announced closure and sale of a distribution facility in the fourth
quarter of 2005, realizing an
$0. This acquisition extends
our product line of Emco Wheaton couplers, added as part of the Syltone
acquisition in 2004, and strengthens the distribution of each company's
products throughout the
world.S."
The Thomas Industries acquisition is expected to contribute net income of
$8.
Selling and administrative expenses increased $15.3
million higher than the net income generated
by this acquisition in 2004. Inventory decreased $7 million in the
fourth quarter of 2005, resulting
in improved turnover, but opportunities for
further reductions exist through the expanded use of
lean manufacturing
techniques and additional supplier performance improvements.6% 7.2 43%
375.2 32.4 21.0% 81.8 8.com
Below are profiles
from PHARMtechexpo exhibitors; breaking news
releases are available at http://www.
Company:
ATMI PACKAGING
Booth/Stand: F06
Media Contact: ISABELLE FOUYN
Phone: +32. the sterilizable
Tyvek(R) Cleansteam(R) bags,
the powder transfer bag and the disposable isolator transfer
packaging
. Raimo Ahola
Phone: +358 6 784 0111
E-mail: info@beamex.co.
We offer a full range of services
to pharmaceutical companies
throughout all phases of the value chain, with emphasis on: Process
research
+ process development, Production of (pre)clinical trial
material, Process optimization, Scale-up
(up scaling)
Company description: DSM is active worldwide in life science and
nutritional
products, performance materials and industrial chemicals. DSM's products are being applied in a wide
range
of end markets and applications such as human and animal nutrition and
health, cosmetics
, pharmaceuticals, automotive and transport,
coatings, housing and electrics + electronics (E + E
).KETOCONAZOLE
10. Festo
employs more than 10. Harro Walger
Phone: +49
-6221-75 901 0
E-mail: info@heipha. Often regarded as the pioneer in the exports of
bulk drugs
from India.wintek kerrick
9% in 2005 from
8."
Outlook
Looking forward, Mr.0% in the three-month
period
ended December 31, 2005, from 32. Increased volume,
especially from fluid transfer products
, and price increases added to this
improvement but were partially offset by changes in foreign currency
exchange
rates.0% in 2005, compared to 32.6% in 2005, compared to 7.
Net income increased
$29.0 million in 2005,
compared to $37.
The following uncertainties and factors, among others
, could affect future
performance and cause actual results to differ materially from those expressed
in or implied by forward-looking statements: (1) the ability to effectively
integrate acquisitions
and realize anticipated cost savings, synergies and
revenue enhancements; (2) the risk that the Company
may incur significant cash
integration costs to achieve any such cost savings; (3) the Company's
exposure
to economic downturns and market cycles, particularly the level of oil and
natural gas
prices and oil and gas drilling and production, which affect
demand for the Company's petroleum products
, and industrial production and
manufacturing capacity utilization rates, which affect demand for
the
Company's compressor and vacuum products; (4) the risks of large or rapid
increases in raw
material costs or substantial decreases in their
availability, and the Company's dependence on particular
suppliers,
particularly iron casting and other metal suppliers; (5) the risks associated
with
intense competition in the Company's markets, particularly the pricing of
the Company's products;
(6) the Company's ability to continue to identify and
complete other strategic acquisitions and effectively
integrate such
acquisitions to achieve desired financial benefits; (7) the risks associated
with
the reduced liquidity generated by the substantial additional
indebtedness incurred to complete
the Thomas Industries acquisition, including
reduced liquidity for working capital and other purposes
, increased
vulnerability to general economic conditions and floating interest rates, and
reduced
financial and operating flexibility due to increased covenant and
other restrictions in the Company
's credit facilities and indentures; (8)
economic, political and other risks associated with the Company
's
international sales and operations, including changes in currency exchange
rates (primarily
between the U.com.
Gardner Denver, Inc.4 71%
Backlog as of 12/31/04
169.6 76%
Fluid Transfer Products
2004
Revenues 48.5 115% 3.4% 38.6 95% 9.com
Web: www.com
Product
description: DSM Pharma Chemicals (DPC) is focused on the
production and development of pharmaceutical
intermediates and active
ingredients - including bulk generics - for the pharmaceutical market.heipha
. Media in
bags up to 200 litres are available for media fills.P.
More than 500 production lines
in 10 production sites worldwide
produce more than 6 billion pharmaceutical containers made of tubing
glass and polymer. Over more than
30 years of experience in the filed of sterile solutions makes
Solupharm to your perfect partner of contract manufacturing. We manufacture and supply a wide range
of positive displacement
pumps.dvp schoolroom
3 million, an 86% increase compared to the same period last year,
as a result of the benefit of acquisitions and flow-through profitability on
organic revenue growth
. We
enter 2006 with a significant level of backlog, and expect demand for these
products to remain
strong into 2007. Todo, with
assembly operations in Sweden and the U. However, in 2006, the
Company
will begin expensing stock options, in accordance with SFAS 123R,
which was adopted on January 1
, 2006. These estimates are based on an assumption that the value of the 2005
stock option grant
recurs in 2006.
Incremental volume and the related benefit of increased cost leverage over
a
higher revenue base, and favorable sales mix, resulted in improved gross
margin percentage (33.5
million in 2004, primarily due to acquisitions.
Comparisons of the financial results for the
three and twelve-month
periods ended December 31, 2005 and 2004 follow., with 2005 revenues of $1
.1 58% 999.5 86%
2005 Orders 76.0%
Depreciation
+ Amortization
2004 5.com
Product description: Envirotainer is committed
to developing and
providing transport solutions based on active temperature-controlled
containers
.DANTROLENE SODIUM
5. MRC offers a full turn key service.
Company: Pharmadule
Booth/Stand: E16
Media Contact: Maria Rosen-Pettersson
Investor Relations Contact: Henrik Cornell
Phone: +46 8 587 420 00
E-mail: info@pharmadule.d.razvitak.com
Web: www.nsb moorfield
We expect that the
combination of cost reductions realized
through acquisition integration, efficiency improvements
, and leverage
associated with revenue growth will more than offset the effect of expensing
stock
options in 2006, resulting in year-over-year operating margin
expansion.7 million to $2. Some acquisition
-related adjustments were recognized
during the fourth quarter, such as reducing pension expense to
reflect the
most recent actuarial valuations.
Revenues for the Compressor and Vacuum Products
segment increased 70% to
$1. This increase was primarily
attributable to acquisitions (net of
cost reductions realized) with operating
margins higher than the Company's previously existing businesses
, cost
reductions and favorable mix.7 7%
2005 Orders 313.2
60% 1,044.8) -1%
Other changes 16.5 14%
2005 Revenues
369.8% 241.3%
Incremental effect of
acquisitions 18.8%
34.
Company: Festo AG + Co.de
Web: www.haupt-pharma.
Company description: heipha is
a leading supplier of ready-to-use
culture media for the pharmaceutical and cosmetic industry.
Company: METRO EXPORTERS PVT. was established in 1989
specialising in the manufacture of equipment
-mainly tanks and pressure
vessels-of different technologies for food and chemical industries and
pharmaceuticals. Scherer GmbH + Co. The
Kinney range of dry, twin rotating screw vacuum pumps
, specially
designed for chemical applications and in line with the ATEX Machinery
Directive.
desuperheaters blowers
Revenues for the three months ended December
31, 2005 were $369.
CEO's Comments Regarding
Results
"I look at 2005 as a year of many successes. Orders for our industrial compressor,
vacuum
and blower products also continued to improve, with very strong growth
in Asia and improving demand
in North America, partially offset by lower
demand for mobile products in Europe and a slower growth
environment, in
general, in this region. For the twelve-
month period of 2005, orders increased
$584.5
million). Capital spending is currently
expected to be approximately $45 million to $50
million in 2006, and will be
used primarily to integrate businesses, introduce new products and improve
operations.98 $0.74 $1.5 611.7 54% 391.4)
-5%
Other changes 47.0 150.9
43%
2004 Orders 47.6 36% 18.76.
Company: DSM Pharma
Chemicals
Booth/Stand: E07
Ticker Symbol + Exchange: DSM - AEX
Media Contact: Herman Wories
Investor Relations Contact: Dries Ausems, investor.FLUCONAZOLE
7.SALBUTAMOL
BASE
15.festo.com
Product description: Festo AG + Co. Almost 800 employees
produce some 2,500 different products for an established clientele of
more than 100 important
international pharmaceutical companies,
amongst which 16 of the international TOP 25.com
Product
description: BULK DRUGS AND PHARMACEUTICALS
- Gastrointestinal
- CNS
- Respiratory
- Cardiovascular
- Allergic disorders
-
Metabolism
- Musculoskeletal
- Antimicrobials + antiinfestives
- Nutrition
- Veterinary
Company description: "Metro Exporters" - a Trading
House based in
Bombay.tappert@schott.
Company: STERIS
Booth/Stand: B09
Ticker Symbol
+ Exchange: NYSE: STE
Media Contact: Kevin Marsh
Investor Relations Contact: Aidan Gormley
Phone:
+44 1256 840400
E-mail: salesinfo@steris. The Kinney range of oil-sealed rotary piston pumps.withee javac
We
expect
to realize the benefit of the liquid ring pump manufacturing rationalization,
which encompasses
a shift in standard product manufacturing from Germany to
China and Brazil, in early 2007."
"In early January, the Company completed the acquisition of the Todo
Group, for a purchase price
of Swedish Krona (SEK) 118.
"Given the current economic environment, as well as our existing
backlog
and recent order trends, we expect DEPS for 2006 to be approximately $3. Based on current
expectations for the sources of earnings in 2006, the
effective tax rate assumed in the DEPS guidance
for 2006 is 30%.3 million for the three
months ended December 31, 2005, compared to the same period
of 2004.7 million in the three-
month period ended December 31, 2005 to $67.9% in 2005,
compared
to 10.5 million in capital expenditures
in 2005, compared to $19.
BUSINESS
SEGMENT RESULTS
(in thousands, except percentages)
(Unaudited)
Three Months Ended Twelve Months Ended
December 31, December 31,
% %
2005 2004 Change
2005 2004 Change
Compressor and
Vacuum Products
Revenues
$306,127 $193,212 58 $999,631 $589,382 70
Operating
earnings 32
,252 14,259 126 86,402 46,681 85
% of Revenues 10.9%
Orders
313,208 195,506 60 1,044,388 611,262 71
Backlog 298,554 169
,894 76 298,554 169,894 76
Fluid Transfer
Products
Revenues
63,160 47,986 32 214,921 150,157 43
Operating
earnings
13,628 7,712 77 34,233 15,069 127
% of Revenues 21.2) -1%
2005 12.2% 242.3 86% 6.com, Business
Wire's trade show, conference
and event news resource.com
Web: www.FLURBIPROFEN
9.000 customers in 176
countries. "Metro" has been a distributor of API's for
human and veterinary medicines Invites visitors
to source products
through Metro's worldwide network of manufacturers.com
Product description:
- Cleanroom Modular Wall and Ceiling System
- Pharmaceutical Doors and Interlock Systems
- Cleanroom Accessories
- Laboratory Furniture
- Fume Cupboards and Extract
Benches
Company description: MRC Systems specialises in the design and
construction of cleanroom
facilities and laboratories for the
pharmaceutical industry. We offer design, project management
and
validation.com
Product description: Complete modular facilities for the
Pharmaceutical
and Biotech industries including: Process Design and
Engineering, Facility Design and Engineering
, Project Management,
Commissioning and Qualification. GMP rules are a guideline of the production
process
and we are in compliance with the international standards USP, EP and
JP.recirculating leybold
QUINCY, Ill
.96, 43% higher than the previous year. Therefore, we enter 2006
with a feeling of cautious optimism
that industrial demand will continue to
expand, albeit slowly, and positively influence demand for
our compressor and
vacuum products. This increase was primarily due to acquisitions,
which contributed
$375.4 million, compared
to the previous year.7 53%
Effect of currency
exchange
rates (9.4%
Other changes 1.1 31% 18
.4% 120.atmi-lifesciences. Through Beamex's partner network, their products and
services are available
in over 60 countries.casburt.
- Hepa filter replacement and testing
- Temperature and
humidity mapping
- Cleanroom training
- Laboratory studies
Company description:
Founded in 1974, Diamond Scientific is an ISO
9001 registered independent consultancy offering the
full range of
validation and testing services to international standards to
cleanroom users.SALBUTAMOL
SULPHATE
16.pharmadule.Scherer is a member of the
"Pharmaceutical Technologies
+ Services" Division of Cardinal Health,
USA.tuthillpump. Tuthill Vacuum + Blower Systems has manufacturing
plants in the USA, Argentina and China.tuthill blowers
Centanni.
Compressor and Vacuum Products segment revenues
increased 58% for the three-
month period of 2005, compared to the previous year, primarily due to
the
incremental effect of acquisitions, improved demand for compressor and blower
products, especially
in the Asian market, and price increases.6 million in 2004.S.m.4 billion on
a pro forma basis including
the acquisition of Thomas Industries, which was
completed in July 2005) is a leading worldwide manufacturer
of reciprocating,
rotary and vane compressors, liquid ring pumps and blowers for various
industrial
and transportation applications, pumps used in the petroleum and
industrial markets, and other fluid
transfer equipment serving chemical,
petroleum, and food industries.5% 7.3 53%
1,214.6 64%
Gross Margin
2004 79.4% 21.0 9
.7 54% 24.1 5.0 80% 5. Business Wire
is the official news wire
service for PHARMtechexpo.com
Product description: Equipment, software and systems for process
instrument calibration, such as portable calibrators, workstations,
calibration software, industry
-specific solutions and professional
services. The
company is a privately owned limited company
.Wories@DSM.com
Web: www.CETIRIZINE DI HCL
19.de
Product description:
Contract manufacturing services: sterile and
non-sterile solutions, semi-solids, suppositories, solid
dosage forms,
capsules and powders for oral solutions. Consulting services:
galenic development
, stability studies, clinical trials, analytical
methods, scaling-up, coordination of bioavailability
/bioequivalence
studies, regulatory affairs, packaging design, logistics.
Company description:
With five production sites and a turnover of
EUR 100 million, Haupt Pharma is one of the leading
contract
manufacturers for pharmaceutical products today.de
Web: www.
Company: RAZVITAK
d.com
Web: www.
Company: Tuthill Pump Group
Booth/Stand: G01
Media Contact: John Westwood
Phone: +44 1323 749021
E-mail: jwestwood@tuthill.vooner withee
2 billion and $67. In 2005, we completed our
largest acquisition to date, Thomas
Industries, which has further diversified our revenue base, expanded
our
presence in higher growth end markets and broadened our sales channels with a
strong focus
on original equipment manufacturers.4 million in 2006, compared to $2.
Fourth Quarter Results
Revenues increased $128.
Orders exceeded revenues during the fourth quarter and for the
full year
of 2005, resulting in backlog increases.1 million, due to the incremental
effect of
acquisitions.1% in the same period of 2004.1 million (64%) to $1.6% in 2004).0% for the twelve-month
period of 2005 from 21. These positive factors were partially offset by
increased material costs
and compensation-related expenses.0% in 2004. This improvement was primarily due to litigation-
related
settlements, the sale of a distribution facility and interest income
earned on the investment of
financing proceeds prior to their use to complete
the acquisition of Thomas Industries. The higher
spending in 2005
reflected a full year of investments in Nash Elmo and six months of capital
spending
on Thomas Industries' operations. Such forward-looking
statements are subject to uncertainties and
factors relating to the Company's
operations and business environment, all of which are difficult
to predict and
many of which are beyond the control of the Company. This free webcast will be available
in listen-only mode and can
be accessed, for up to ninety days following the call, through the Investor
Relations page on the Gardner Denver website (http://www.1) --
Other changes
16.2 32% 214.8 21% 2.6 26% 2.9% 67.ALBUTEROL SULPHATE
18. Festo supplies products, systems and services
suitable for factory and process
automation applications to more than
300. Muller GmbH
Booth/Stand: C 17
Media Contact: Dr.
hr
Product description: We are producing hard gelatine capsules in
five sizes: "0", "1", "2
", "3", and "4".
Company description: Solupharm is a contract manufacturer of
sterile parenteralia
in glass ampoules or glass vials.com
Product description: Vacuum pumps, vacuum boosters and systems
.travaini priming
Working overtime to stay the Web's best reference!
-> Show SiteSeek's List of Web Sites For This Topic (Not Yet Peer Reviewed)
Loading...
(Note: These pages use the Atlas Content Safeguard System (ACSS) and require that Javascript is enabled for viewing.)